Twist Bioscience Corporation (TWST)

USD 44.61

(-7.83%)

Gross Profit Summary of Twist Bioscience Corporation

  • Twist Bioscience Corporation's latest annual gross profit in 2024 was 133.34 Million USD , up 48.61% from previous year.
  • Twist Bioscience Corporation's latest quarterly gross profit in 2024 Q2 was 30.88 Million USD , up 6.63% from previous quarter.
  • Twist Bioscience Corporation reported a annual gross profit of 89.72 Million USD in annual gross profit 2023, up 6.52% from previous year.
  • Twist Bioscience Corporation reported a annual gross profit of 84.23 Million USD in annual gross profit 2022, up 62.89% from previous year.
  • Twist Bioscience Corporation reported a quarterly gross profit of 30.88 Million USD for 2024 Q2, up 6.63% from previous quarter.
  • Twist Bioscience Corporation reported a quarterly gross profit of 35.27 Million USD for 2024 Q3, up 14.21% from previous quarter.

Annual Gross Profit Chart of Twist Bioscience Corporation (2024 - 2016)

Historical Annual Gross Profit of Twist Bioscience Corporation (2024 - 2016)

Year Gross Profit Gross Profit Growth
2024 133.34 Million USD 48.61%
2023 89.72 Million USD 6.52%
2022 84.23 Million USD 62.89%
2021 51.71 Million USD 80.22%
2020 28.69 Million USD 312.33%
2019 6.95 Million USD 202.91%
2018 -6.76 Million USD 48.98%
2017 -13.25 Million USD -85.3%
2016 -7.15 Million USD 0.0%

Peer Gross Profit Comparison of Twist Bioscience Corporation

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -1293.989%
Prenetics Global Limited 8.82 Million USD -1410.201%
Star Equity Holdings, Inc. 11.92 Million USD -1018.137%
CareDx, Inc 178.32 Million USD 25.221%
Exact Sciences Corporation 1.84 Billion USD 92.774%
Exagen Inc. 29.45 Million USD -352.706%
Inotiv, Inc. 165.44 Million USD 19.399%
Guardant Health, Inc. 336.89 Million USD 60.418%
Biodesix, Inc. 36.07 Million USD -269.623%
BioNexus Gene Lab Corp. 1.32 Million USD -9930.026%
Precipio, Inc. 6.01 Million USD -2115.836%
iSpecimen Inc. 5.1 Million USD -2510.634%
Natera, Inc. 492.74 Million USD 72.937%
Aspira Women's Health Inc. 5.26 Million USD -2434.189%
Standard BioTools Inc. 50.45 Million USD -164.319%
23andMe Holding Co. 99.37 Million USD -34.185%
Castle Biosciences, Inc. 174.8 Million USD 23.716%
Personalis, Inc. 18.2 Million USD -632.365%
Aclaris Therapeutics, Inc. 13.16 Million USD -912.675%
Applied DNA Sciences, Inc. 5.53 Million USD -2309.879%
OpGen, Inc. -90.69 Thousand USD 147131.777%
T2 Biosystems, Inc. -8.17 Million USD 1732.179%
Myriad Genetics, Inc. 476.4 Million USD 72.009%
ICON Public Limited Company 1.81 Billion USD 92.65%
NeoGenomics, Inc. 244.6 Million USD 45.484%
Star Equity Holdings, Inc. 11.92 Million USD -1018.137%
IDEXX Laboratories, Inc. 2.18 Billion USD 93.911%
RadNet, Inc. 93 Million USD -43.386%
MDxHealth SA 43.92 Million USD -203.556%
Psychemedics Corporation 8.41 Million USD -1485.035%
Illumina, Inc. 2.74 Billion USD 95.14%
Check-Cap Ltd. -212 Thousand USD 63000.472%
DarioHealth Corp. 5.98 Million USD -2128.426%
Fulgent Genetics, Inc. 104.45 Million USD -27.66%
Sera Prognostics, Inc. 96 Thousand USD -138805.208%
ENDRA Life Sciences Inc. -275.45 Thousand USD 48511.151%
OPKO Health, Inc. 318.12 Million USD 58.083%
Medpace Holdings, Inc. 524.5 Million USD 74.576%
Neogen Corporation 463.9 Million USD 71.255%
Intelligent Bio Solutions Inc. 1.42 Million USD -9253.715%
Prenetics Global Limited 8.82 Million USD -1410.201%
Mainz Biomed B.V. 509.65 Thousand USD -26064.357%
bioAffinity Technologies, Inc. 791.61 Thousand USD -16745.184%
Trinity Biotech plc 19.45 Million USD -585.599%
Neuronetics, Inc. 51.7 Million USD -157.903%
Sotera Health Company 577.15 Million USD 76.896%
bioAffinity Technologies, Inc. 791.61 Thousand USD -16745.184%